← Back to Search

Behavioral Intervention

Dairy vs Carbs vs Water for Bone Health and Inflammation (BIONEX Trial)

N/A
Recruiting
Led By Andrea R Josse, PhD
Research Sponsored by York University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18-30 years
On no medication related to a chronic condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours post-exercise
Awards & highlights

BIONEX Trial Summary

This trial tests if dairy can help bones & reduce inflammation after exercise in healthy young adults, compared to carbs or water.

Who is the study for?
This trial is for healthy young adults aged 18-30 with a normal BMI who are low to moderately active. Participants must either be on birth control or have regular menstrual cycles, and not be taking medication for chronic conditions. They should not have allergies to dairy protein, lactose intolerance, or smoke regularly.Check my eligibility
What is being tested?
The study is examining if consuming dairy products like Greek yogurt and skim milk can influence bone health and reduce inflammation after high-intensity exercise compared to just having a carbohydrate drink (maltodextrin powder in water) or plain water.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort due to dairy consumption, especially in individuals who might discover they are sensitive to lactose despite no known intolerance. High-intensity exercise may also cause muscle soreness.

BIONEX Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 30 years old.
Select...
I am not on any medication for a chronic condition.

BIONEX Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours post-exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours post-exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute Bone Turnover/Cell Activity
Systemic Inflammation - Serum/Plasma Cytokines
Systemic inflammation - Immune Cells
Secondary outcome measures
Muscle soreness
Performance - Jump Height

BIONEX Trial Design

4Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Exercise and Milk (Milk)Experimental Treatment2 Interventions
Participants will have a fasted baseline blood sample taken upon arrival to the lab. Then they will take part in a high-intensity exercise protocol, consisting of high-intensity interval cycling, resistance exercise, and plyometrics. Following exercise, participants will return to the lab for a 5min post-exercise blood sample, and then consume ~500ml plain skim milk (0% milk fat). An additional blood sample will be taken at 1h post-exercise, followed by an additional ~500ml of skim milk. Blood samples will also be taken at 4h and 24h post-exercise. Participants will also rate their muscle soreness and perform a jump height test at pre-exercise, 5min post-exercise, 4h and 24h post-exercise.
Group II: Exercise and Greek Yogurt (GY)Experimental Treatment2 Interventions
Participants will have a fasted baseline blood sample taken upon arrival to the lab. Then they will take part in a high-intensity exercise protocol, consisting of high-intensity interval cycling, resistance exercise, and plyometrics. Following exercise, participants will return to the lab for a 5min post-exercise blood sample, and then consume ~200g Greek yogurt (0% milk fat). An additional blood sample will be taken at 1h post-exercise, followed by an additional ~200g of Greek yogurt. Blood samples will also be taken at 4h and 24h post-exercise. Participants will also rate their muscle soreness and perform a jump height test at pre-exercise, 5min post-exercise, 4h and 24h post-exercise.
Group III: Exercise and Carbohydrate (CHO)Active Control2 Interventions
Participants will have a fasted baseline blood sample taken upon arrival to the lab. Then they will take part in a high-intensity exercise protocol, consisting of high-intensity interval cycling, resistance exercise, and plyometrics. Following exercise, participants will return to the lab for a 5min post-exercise blood sample, and then consume ~50g of maltodextrin mixed with water (~500ml). An additional blood sample will be taken at 1h post-exercise, followed by an additional ~500ml of the maltodextrin drink. Blood samples will also be taken at 4h and 24h post-exercise. Participants will also rate their muscle soreness and perform a jump height test at pre-exercise, 5min post-exercise, 4h and 24h post-exercise.
Group IV: Exercise and Water (W)Placebo Group2 Interventions
Participants will have a fasted baseline blood sample taken upon arrival to the lab. Then they will take part in a high-intensity exercise protocol, consisting of high-intensity interval cycling, resistance exercise, and plyometrics. Following exercise, participants will return to the lab for a 5min post-exercise blood sample, and then consume ~500ml water. An additional blood sample will be taken at 1h post-exercise, followed by an additional ~500ml water. Blood samples will also be taken at 4h and 24h post-exercise. Participants will also rate their muscle soreness and perform a jump height test at pre-exercise, 5min post-exercise, 4h and 24h post-exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Skim Milk
2018
N/A
~80
Greek yogurt
2011
N/A
~40

Find a Location

Who is running the clinical trial?

York UniversityLead Sponsor
58 Previous Clinical Trials
17,451 Total Patients Enrolled
3 Trials studying Inflammation
85 Patients Enrolled for Inflammation
Andrea R Josse, PhDPrincipal InvestigatorYork University
1 Previous Clinical Trials
13 Total Patients Enrolled
1 Trials studying Inflammation
13 Patients Enrolled for Inflammation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the demographic for this clinical trial restricted to a specific age range?

"This clinical trial limits enrolment to individuals between 18 and 30 years old, as per the eligibility criteria."

Answered by AI

Are there any qualifications needed to partake in this trial?

"This trial is accepting 25 individuals between 18 and 30 years old with inflammation. To qualify, participants must not possess any anaphylactic response to dairy proteins or lactose intolerance."

Answered by AI

Does this clinical experiment still have vacancies for test subjects?

"Contrary to the information on clinicaltrials.gov, this particular study is no longer actively recruiting patients after its most recent update of September 13th 2023. But with 1193 other medical trials in operation at present, there are plenty of opportunities for participation elsewhere."

Answered by AI
~15 spots leftby Dec 2024